| 3101 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
20 |
| 3102 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
74 |
| 3103 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 3104 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
56 |
| 3105 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
48 |
| 3106 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 3107 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 3108 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
48 |
| 3109 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 3110 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
52 |
| 3111 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
50 |
| 3112 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
61 |
| 3113 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
35 |
| 3114 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
61 |
| 3115 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
47 |
| 3116 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
34 |
| 3117 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 3118 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 3119 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 3120 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3121 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 3122 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3123 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 3124 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
39 |
| 3125 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
43 |
| 3126 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3127 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
21 |
| 3128 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
58 |
| 3129 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
45 |
| 3130 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
63 |
| 3131 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
54 |
| 3132 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
48 |
| 3133 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
61 |
| 3134 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
27 |
| 3135 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
61 |
| 3136 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
66 |
| 3137 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
47 |
| 3138 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Germany |
55 |
| 3139 |
Apheresis |
Allogeneic |
Acute Promyelocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 3140 |
Apheresis |
Allogeneic |
Acute Promyelocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
40 |
| 3141 |
Apheresis |
Allogeneic |
Alk-Positive Anaplastic T-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 3142 |
Apheresis |
Autologous |
Anaplastic Large Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
22 |
| 3143 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
22 |
| 3144 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 3145 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 3146 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Germany |
67 |
| 3147 |
Apheresis |
Allogeneic |
Atypical Chronic Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 3148 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 3149 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 3150 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
54 |
| 3151 |
Apheresis |
Allogeneic |
Beta Thalassemia Major |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 3152 |
Apheresis |
Allogeneic |
C-All Rez (Acute Lymphoblastic Leukemia) |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 3153 |
Apheresis |
Allogeneic |
C-All Rez (Acute Lymphoblastic Leukemia) |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 3154 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 3155 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 3156 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 3157 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3158 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 3159 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
58 |
| 3160 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia Richter Transformation 7/22 |
Hematology |
2022 |
Standard Therapy |
Poland |
44 |
| 3161 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3162 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 3163 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3164 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 3165 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3166 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 3167 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
70 |
| 3168 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 3169 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3170 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 3171 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 3172 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 3173 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0) |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3174 |
Apheresis |
Allogeneic |
Chronic Neutrophilic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 3175 |
Apheresis |
Allogeneic |
Chronic Neutrophilic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
72 |
| 3176 |
Apheresis |
Allogeneic |
Combined Immunodeficiency Syndrome With Hyper-Igm |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 3177 |
Apheresis |
Allogeneic |
Congenital Dyserythropoietic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 3178 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
68 |
| 3179 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
65 |
| 3180 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
69 |
| 3181 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
50 |
| 3182 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
56 |
| 3183 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
65 |
| 3184 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
47 |
| 3185 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma – Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
66 |
| 3186 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
66 |
| 3187 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2022 |
Standard Therapy |
Germany |
39 |
| 3188 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2022 |
Standard Therapy |
Germany |
33 |
| 3189 |
Apheresis |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 3190 |
Apheresis |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2022 |
Standard Therapy |
Poland |
21 |
| 3191 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
26 |
| 3192 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
31 |
| 3193 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
53 |
| 3194 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 3195 |
Apheresis |
Autologous |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
67 |
| 3196 |
Apheresis |
Autologous |
Hodgkin Lymphoma-Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
69 |
| 3197 |
Apheresis |
Autologous |
Hodgkin Lymphoma-Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
48 |
| 3198 |
Apheresis |
Allogeneic |
Hypoplastic Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
26 |
| 3199 |
Apheresis |
Allogeneic |
Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 3200 |
Apheresis |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |